Application
Formalin-fixed and paraffin-embedded human hepatocarcinoma with NAT2 Antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining.
Application
Flow cytometric analysis of HepG2 cells using NAT2 Antibody (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
Application
Western blot analysis of NAT2 using rabbit polyclonal NAT2 Antibody using 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the NAT2 gene.
Application
Western blot analysis of NAT2 Antibody in mouse kidney tissue lysates (35ug/lane)
WB
(A–L) Cropped images showed protein expression levels of CYP2C19, NAT2, NFKBIβ, EGFR, FOS, NFKB1, PPARα, RXRα, RXRβ, TPMT, UGCG, and XPC in DLD-1 WT and DLD-1 BAX–BAK DKO cells. Bar charts presented relative changes of mean gray value, which was normalized to that of β-actin.
WB
(A–L) Cropped images showed protein expression levels of CYP2C19, NAT2, NFKBIβ, EGFR, FOS, NFKB1, PPARα, RXRα, RXRβ, TPMT, UGCG, and XPC in DLD-1 WT and DLD-1 BAX–BAK DKO cells. Bar charts presented relative changes of mean gray value, which was normalized to that of β-actin.